藥物成份

共有 21678 個藥物成份

AxSYM HAVAB 2.0 Reagent pack1 Bottle (3.45ml) Hepatitis A Viurs (Human) coatedmicroparticles in TRIS buffer with protein stabilizers. Minimumconcentration: 0.05% solids. Preservative: Sodium Azide.(Reagent bottle 2)1 Bottle (11.71ml) Antibody to Hepatitis A virus antigen (Human):Alkaline phosphatase conjugate in TRIS buffer with proteinstabilizers. Minimum concentration:1.5ug /ml. Preservative:Sodium azide and antimicrobial agents. (Reagent bottle 1)1 Bottle (2.8 ml) AxSYM HAVAB 2.0 Index Calibrator is prepared in fetal bovine serum.Preservatives: Sodium azide, Dye: Green (Acid yellow NO.23 and acid blue No.9).AxSYM HAVAB 2.0 controls 2 Bottles (9ml each) of AxSYM HAVAB 2.0 controls. The negative control is fetal bovine serum. The positive control contains purified anti-HAV (human,nonreactive for HBsAg, HIV-1 Ag, anti-HCV, and anti-HIV-1/HIV-2, by FDA licensed tests) prepared in fetal bovine serum.Preservative : Sodium azide.AxSYM HAVAB 2.0 Quantitative Standard calibrators 6 Bot

• 關聯藥證數量: 1

AxSYM HBe 2.0 Reagent Pack1. 1 Bottle(6.9ml) Antibody to Hepatitis B e Antigen (Mouse, Monoclonal) Coated microparticles in TRIS buffer with protein stabilizers. Minimum concentration: 0.005% solids. Preservative: Sodium azide.2. 1 Bottle(10.3ml) Antibody to Hepatitis B e Antigen (Mouse, Monoclonal):Alkaline Phosphate Conjugate in HRIS buffer with protein stabilizers. Minimum concentration: 0.1ug/ml. Preservatives: Sodium azide and antimicobial agents.3. 1 Bottle(19.2ml) Wetting solution prepared TRIS buffer with protein stabilizers. Preservative: Antimicrobial agents.4. 1 Bottle(50.2ml) Specimen diluent containing sodium chloride in TRIS buffer. Preservatives: Sodium azide and antimicrobial agents.1 Bottle(4ml) AxSYM HBe 2.0 Index Calibrator (concentration:0.280PEI U/ml) containing recombinant DNA derived HbeAg in TRIS buffer with protein stabilizers. Preservative: Sodium azide.AxSYM HBe 2.0 Controls1 Bottle (9.0ml) of AsSYM HBe 2.0 Negative control is prepared in TRIS buffer with protein staAxSYM HBe 2.0 Re

• 關聯藥證數量: 1

AxSYM HBsAg Reagent Pack？ 1 bottle (5.1ml) Anti-HBs (Mouse, Monoclonal, IgM) Coated Microparticles in phosphate buffer with protein stabilizers. Minimum concentration: 0.15%？ 1 bottle (15.5ml) Anti-Biotin (Rabbit): Alkaline Phospatase Conjugate in TRIS buffer with (Rabbit) IgG. Minimum concentration: 0.03μg/ml ？ 1 bottle (17.6ml) Biotinylated Anti-HBs (Goat, IgG) in TRIS buffer concentration animal sera (Goat, Calf, Rabbit, Mouse).Minium concentration: 0.25μg/ml.？ 1 Bottle (6ml) AxSYM HbsAg (V2) Index Calibrator, Recalcified human plasma nonreactive for HbsAg, anti-HBs, anti-HCV and anti-HIV-1/HIV-2. AxSYM HbsAg ControlsTwo bottles (8ml each) of AxSYM Controls are prepared with recalcified human plasma. The Negative Control is nonreactive for HbsAg, anti-HBs anti-HCV and anti-HIV-1/HIV-2. The Positive Control is positive for HBsAg and nonreactive for anti-HBs and anti-HIV-1. AxSYM Probe Cleaning Solution 4 bottles (110ml each) containing 2% TEAHSolution 1 (MUP) 4 bottles (230ml each) cont

• 關聯藥證數量: 1

AxSYM HCV version 3.0 Reagent Pack 1 bottle(9.9ml) HCV Antigen Coated Microparticles 1 bottle(12.1ml) Goat Anti-Human IgG:Alkaline Phosphatase Conjugate 1 bottle(28ml) Specimen Diluent 2 1 bottle(50.2ml) Specimen Diluent 1 1 bottle(2.0ml) AxSYM HCV 3.0 Index Calibrator. Recalcified human plasma,reactive for anti-HCV and nonreactive for HBsAg and anti-HIV-1/HIV-2)AxSYM HCV version 3.0 Controls Two bottles (7ml each) of AxSYM HCV version 3.0 Controls are prepared with recalcified human plasma. The Negative Control is nonreactive for anti-HCV, HBsAg and anti-HIV-1/HIV-2. The Positive Control is recalcified human plasma reactive for anti-HCV, and non reactive for HBsAg and anti-HIV-1/HIV-2.Axsym Probe Cleaning Solution 4 Bottles (110ml each) AxSYM Probe Cleaning Solution containing 2% Tetraethylammoniumhydroxide (TEAH).Solution 1(MUP) 4 Bottles (230ml each) Solution 1(MUP) containing 4-Methylumbelliferyl Phosphate,1.2mMSolutoin 3(Matrix Cell Wash) 4 Bottles (1000ml

• 關聯藥證數量: 1

AxSYM HIV 1/2 Reagent pack1. 1 Bottle (11.7ml)Anti-Biotin (Rabbit):Alkaline Phosphate Conjugate in TRIS buffer with protein stabilizers. Minimum concentration: 0.03ug/ml. Preservative: Sodium Azide.2. 1 Bottle (6.8ml) HIV-1/HIV-2 (E. coli, B.megaterium, recombinants) Antigen coated microparticles in TRIS buffer. Minimum concentration:0.01% solids. Preservative:Sodium Azide.3. 1 Bottle (14.3ml) Biotinylated HIV-1/HIV-2 (E.coli, recombinant and synthetic peptides) Antigens in TRIS buffer with surfactant. Minimum concentration: 100ng/ml. Preservatives: Sodium Azide. ProClin 300.4. 1 Bottle (37.6ml) Specimen diluent in TRIS buffer with surfactant. Preservatives:Sodium Azide, ProClio 300.5. 1 Bottle (2.8ml) AxSYM HIV 1/2 g0 Index Calibrator. Recalcified human plasma, nonreactive for HBsAg, HIV-1 Ag, Anti-HBs, anti-HCV and anti-HIV-1/HIV-2. Preservatives: Sodium Azide.AxSYM HIV 1/2 g0 control: Negative control, HIV-1 Positive control and HIV-2 positive control 3 Bottles (8ml of each) of AxSYM HIV 1/

• 關聯藥證數量: 1

AxSYM HbA1c Controls (# 3L93-10)\n2 Bottles (5.0 mL each) of AxSYM HbA1c Controls. The controls yield the concentrations (% HbA1c)

• 關聯藥證數量: 1

AxSYM HbA1c Reagent Pack (# 3L93-20)\n1 Bottle (15.9 mL) Anti-HbA1c Antibody：Alkaline Phosphatase Conjugate in TRIS buffer with protein stabilizers. Minimum concentration：1 μg/mL\n1 Bottle (10.9 mL) Sample Diluent in TRIS buffer.\n1 Bottle (20.5 mL) Blocking Buffer in TRIS buffer.\n1 Bottle (38.4 mL) Lysis Buffer containing detergent.

• 關聯藥證數量: 1

AxSYM HbA1c Standard Calibrators (# 3L93-01)\n6 Bottles (2.0 mL each) of AxSYM HbA1c Standard Calibrators. The calibrators yield the concentrations (% HbA1c)：Standard CAL A：4.0、Standard CAL B：5.5、Standard CAL C：7.5、Standard CAL D：9.0、Standard CAL E：12.0、Standard CAL F：14.5

• 關聯藥證數量: 1

AxSYM Homocysteine Reagent Pack:\n？ 1 Bottle (15.0mL) S-adenosyl-L-cysteine Fluorescein Tracer in phosphate buffer\n？ 1 Bottle (12.4mL) S-adenosyl-L-homocysteine Hydrolase (bovine) in phosphate buffer.\n？1 Bottle (15.6mL) Anti-S-adenosyl-L-homocysteine (mouse, monoclonal) in phosphate buffer \n？1 Bottle (15.3mL) Pretreatment Solution containing dithiothreitol (DTT) and adenosine in citric acid.\nHomocysteine Calibrators\n？1 Bottle (3.5mL) Homocysteine Calibrator A \n？5 Bottles (2.5mL each) of Homocysteine Calibrators B-F \nCAL A：0.0μmol/L\nCAL B：2.5μmol/L\nCAL C：5.0μmol/L\nCAL D：10.0μmol/L\nCAL E：20.0μmol/L\nCAL F：50.0μmol/L\nHomocysteine Controls3 Bottles (2.5mL each) of Homocysteine Controls CONTROL L：7.0μmol/LCONTROL M：12.5μmol/LCONTROL H：25.0μmol/L

• 關聯藥證數量: 1

AxSYM LH Reagent Pack1.1 Bottle (7.5 mL) Anti-LH coated Microparticles in TRIS buffer.2.1 Bottle (14.2 mL) Anti-LH: Alkaline Phosphatase Conjugated in TRIS buffer with protein stabilizers.3.1 Bottle (26.5 mL) TRIS buffer with 0.3M Sodium Chloride. AxSYM LH Standard Calibrators 6 Bottles (4mL each) with (human) pituitary LH in Calf serum at 0, 2, 10, 25, 100 and 250 mIU/mL (CAL A to F, respectively).AxSYM LH Controls 3 Bottles (8mL each) with (human) pituitary LH in processed bovine serum at 5, 40 and 80 mIU/mL (CONTROL L, M and H, respectively).

• 關聯藥證數量: 1

AxSYM Phenytoin Reagent Pack1 Bottle (14.5mL) <1% Phenytoin Antiserum. 1 Bottle (8.6mL) Pretreatment Solution.1 Bottle (15.1mL) <0.01% Phenytoin Fluorescein Tracer.6 Bottles (6 mL A, 4mL each B-F) of AxSYM Phenytoin Standard Calibrators contain accurately measured amounts of Phenytoin prepared in human serum. from 0.0 to 40.0 mg/LAxSYM Phenytoin Controls3 Bottles (8mL each) of AxSYM Phenytoin controls contain Phenytoin prepared in human serum

• 關聯藥證數量: 1

AxSYM Progesterone Reagent Pack, 100 Tests\n1 Bottle (9.3 mL) Progesterone Buffer. Phosphate buffer with protein (bovine, murine and sheep) stabilizers. (Reagent Bottle 1)\n1 Bottle (9.3 mL) Anti-Progesterone (Sheep, monoclonal): Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine) stabilizrs. Minimum concentration: 0.02μg/mL. (Reagent Bottle 2)\n1 Bottle (12.8 mL) Progesterone Microparticles in TRIS buffer with protein (bovine and murine) stabilizers. (Reagent Bottle 3)\nAxSYM Progesterone Standard Calibrators (concentration: 0, 0.7, 2, 7, 20, 40 ng/mL)\nAxSYM Progesterone Standard Controls (concentration: 1, 5.5, 22 ng/mL)\n

• 關聯藥證數量: 1

AxSYM Prolactin Reagent Pack 1 Bottle (9.3mL) Anti-Prolactin coated Microparticles. 1 Bottle (9.0mL) Anti-Prolactin: Alkaline Phosphatase Conjugate. 1 Bottle (11.4mL) Assay Diluent.Prolactin Calibrators 1 Bottle (4mL) Prolactin Calibrator A contains 5 Bottle (4mL each) Prolactin Calibrator B-F contain 0, 5, 10, 30, 80, 200 ng/mL.Prolactin Controls 3 Bottle (8mL each) of Prolactin Controls contain Prolactin (Conc. 8, 20, 40 ng/mL)

• 關聯藥證數量: 1

AxSYM Rubella IgM Controls 1 Bottles (5mL) AxSYM Rubella IgM Negative Control ( Index : 0.000) 1 Bottle (5mL) AxSYM Rubella IgM Positive Control ( Index : 1.500)

• 關聯藥證數量: 1

AxSYM Rubella IgM Index Calibrators 1 Bottle (3mL) AxSYM Rubella IgM Index Calibrators.

• 關聯藥證數量: 1

AxSYM Rubella IgM reagent Pack 1. 1 Bottle (8.8mL) partially purified Rubella Virus coated Microparticles in Tris buffer with protein stabilizers.

• 關聯藥證數量: 1

AxSYM Salicylate Reagent Pack？1 Bottle (4.8mL) <0.01% Salicylate Fluorescein Tracer.？1 Bottle (3.5mL) <25% Salicylate Antiserum (Sheep and Rabbit).？1 Bottle (4.4mL) Pretreatment Solution.6 Bottles (2.5mL each) of XSYSTEMS Salicylate Calibrators, 0, 50, 100, 200, 400, 800 mg/L.3 Bottles (2.5mL each) of XSYSTEMS Salicylate Controls, 75, 300 and 600 mg/L.

• 關聯藥證數量: 1

AxSYM Theophylline II Reagent Pack1 Bottle (14.5mL)<0.05% Theophylline II Antiserum (Mouse, Monoclonal).1 Bottle (8.6mL) Pretreatment Solution1 Bottle (15.1mL)<0.01% Theophylline II Fluorescein Tracer in TRIS buffer.6 Bottle (5mL A, 4mL each B-F) of AxSYM Theophylline II Standard Calibrators Tehophylline Concentratin, A: 0; B:2.5; C:5.0; D:10.0; E:20.0; F:40.0 mg/LAxSYM Theophylline II Controls3 Bottles (8mL each) of AxSYM Theophylline II Controls L 7.0 mg/L M 12.0 mg/L H 26.0 mg/L

• 關聯藥證數量: 1

AxSYM Tobramycin Standard Calibrators (concentration:1.0, 4.0, 8.0 mg/L)

• 關聯藥證數量: 1

AxSYM Tobramycin Standard Calibrators (concentration:0, 0.5, 1.5, 3.0, 6.0, 10.0 mg/L)

• 關聯藥證數量: 1

AxSYM Total T3 Reagent Pack 1 Bottle(13.9 ml)T3：Alkaline Phosphatase Conjugate in Tromethamine HCl buffer with protein (bovine) stabilizers. 1 Bottle(6.4 ml)Anti-T3 (Sheep,Monoclonal)Coated Microparticles in TRIS buffer with protein (bovine) stabilizers. 1 Bottle (26.5 ml)TRIS Buffer.Preservatives：Sodium Azide and Antimicrobial Agents. AxSYM Total T3 Standard Calibrators 6 Bottles (4 mL each) of Total T3 Calibrators,A-F, concentration：0, 0.5, 1, 2, 4 and 8 ng/mL. AxSYM Total T3 Controls 3 Bottles(8 mL each) of Total T3 Controls,0.7, 1.5 and 3.7 ng/mL

• 關聯藥證數量: 1

AxSYM Total T4 Controls (concentration: 4.5, 8.0, 15.0 μg/dL)

• 關聯藥證數量: 1

AxSYM Total T4 Reagent Pack: 1 Bottle (4.8mL) T4 Pretreatment Solution. Surfactant in TRIS buffer 1 Bottle (3.5mL) T4 Antiserum (Mouse, Monoclonal) in phosphate buffer with protein stabilizers 1 Bottle (10mL) T4 Fluorescein Tracer in TRIS buffer containing surfactant.

• 關聯藥證數量: 1

AxSYM Total T4 Standard Calibrators (concentration: 0, 3.0, 6.0, 12.0, 18.0, 24.0 μg/dL)

• 關聯藥證數量: 1

AxSYM Toxo IgG Reagent Pack\n1 Bottle (7.8 mL). \n1 Bottle (9.6 mL).\n1 Bottle (25.8 mL). \Toxo IgG Calibrators \n1 Bottle (3 mL) of Toxo IgG Calibraotr (A).\n5 Bottle (3 mL each) of Toxo IgG Calibrators (B-F). \nToxo IgG Controls \n1 Bottle (5 mL) Toxo IgG Negative Control. \n1 Bottle (5 mL) Toxo IgG Positive Control.

• 關聯藥證數量: 1

AxSYM Toxo IgM Controls : \n AxSYM Toxo IgM Negative Control prepared with recalcified human plasma nonreactive for HBsAg, HIV-1 Ag or HIV-1 NAT, anti-HCV, anti-HIV-1/HIV-2 and T. gondii IgM Ab.\n AxSYM Toxo IgM positive Control prepared with recalcified human plasma reactive for T. gondii IgM Ab and nonreactive for HBsAg , HIV-1 Ag or HIV-1 NAT, anti-HCV and anti-HIV-1/HIV-2.

• 關聯藥證數量: 1

AxSYM Toxo IgM Reagent Pack : \n T. gondii Coated Microparticles in Tris buffer. \n Anti-Human IgM (goat) : Alkaline Phosphatase Conjugate in Tris buffer. \n Assay Diluent in Tris buffer. \n RF Neutralization Buffer, Citrate.\n\nAxSYM Toxo IgM Index Calibrator : \n AxSYM Toxo IgM Index Calibrator prepared with recalcified human plasma reactive for T. gondii IgM Ab and nnreactive for HBsAg, HIV-1 Ag or HIV-1 NAT, anti-HCV and anti-HIV-1/HIV-2.

• 關聯藥證數量: 1

AxSYM Troponin-I ADV Reagent Pack1 Bottle (13.1mL) Conjugate 2, Anti-biotin (mouse monoclonal): alkaline phosphatase (E.coli) conjugate.1 Bottle (4.9mL) Microparticles, Anti-troponin-I (mouse monoclonal) coated microparticles.1 Bottle (13.7mL) Conjugate 1, Anti-troponin-I (mouse monoclonal):biotin conjugate in TRIS buffer with protein (mouse and bovine) stabilizers.1 Bottle (17.0mL) Pre-INCUBATION Diluent, Diluent containing protein (mouse, goat, bovine, and E. coli lysate). 6 Bottles (4mL each) of AxSYM Troponin-I ADV Standard Calibrators (Conc.0-22.78 ng/mL)3 Bottles (8mL each) of AxSYM Troponin-I ADV Controls (Conc. 0.28-9.49 ng/mL)

• 關聯藥證數量: 1

Azacitidine Assay: 98.0%~102.0% on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Azacitidine contains not less than 98.0 percent and not more than 102.0 percent of C8H12N4O5 calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Azathioprine (Process 2) contains not less than 98.5% and not more than 101.0% of C9H7N7O2S, calculated on anhydrous basis.

• 關聯藥證數量: 1

Azathioprine contains not less than 98.0% and not more than 101.5% of C9H7N7O2S calculated on the dried basis.

• 關聯藥證數量: 1

Azelaic acid contains not less 99.2% of C9H16O4

• 關聯藥證數量: 1

Azilsartan Kamedoxomil contains not less than 97.0% and not more than 102.0% of C30H23KN4O8, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 945 ug/mg~1030 ug/mg of C38H72N2O12, calculated on dried basis.

• 關聯藥證數量: 1

Azithromycin (Dihydrate) Content： 96.0%~102.0% on the anhydrous basis

• 關聯藥證數量: 1

Azithromycin 0.016-256 μg/mL。處方變更為：空白(核定事項另載於中文仿單)。

• 關聯藥證數量: 1

Azithromycin Dihydrate 94.5% - 103.0% of C38H72N2O12, calculated on anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 2 molecules of water of hydration. It contains the equivalent of not less than 945 μg/mg and not more than 1030 μg/mg of azithromycin (C38H72N2O12), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains 96.0%~102.0% of C38H72N2O12, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 945μg/mg And not more than 1030μg/mg of C38H72N2O12, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than 102.0% of C38H72N2O12‧2H2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than 102.0% of C38H72N2O12‧xH2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Azithromycin contains not less than 96.0% and not more than102.0% of C38H72N2O12‧xH2O calculated on the anhydrous substance.

• 關聯藥證數量: 1

Aztreonam

• 關聯藥證數量: 1

Aztreonam：0.016-256 μg/mL。處方變更為：空白(核定事項另載於中文仿單)。

• 關聯藥證數量: 1

Azulene Water Soluble contains not less than 98.5% and not more than 101.5% of C15H17NaO3S.1/2H2O.

• 關聯藥證數量: 1

A：Buffer sol.(R-1)\nB：Substrate sol.(R-2)

• 關聯藥證數量: 1

A：Reconstituting Solution(Liquid)\nB：Sample Diluent(Liquid)\nC：Sensitized Particles(Lyophilized)\nD：Unsensitized Particles(Lyophilized)\nE：Positive Control(Lyophilized)

• 關聯藥證數量: 1

B. MULTICINCTUS ANTIVENIN

• 關聯藥證數量: 1

B. MULTICINCTUS ANTIVENIN BIVALENT

• 關聯藥證數量: 1

B.C.G. VACCINE

• 關聯藥證數量: 1

B.H.T

• 關聯藥證數量: 1

B.H.T.

• 關聯藥證數量: 1

B.R.A.H.M.S CEA KRYPTOR CAL：Each vial contains highly purified human CEA, human serum.

• 關聯藥證數量: 1

B.R.A.H.M.S FSHKRYPTOR CAL:Each vial contains human FSH, new born calf serum,.

• 關聯藥證數量: 1

B.R.A.H.M.S Ferritin KRYPTOR CAL: Each vial contains highly purified human ferritin, human serum.

• 關聯藥證數量: 1

B.R.A.H.M.S Ferritin KRYPTOR QC: Each vial contains purified human ferritin and human serum.

• 關聯藥證數量: 1

B/AUSTRIA/1359417/2021 - LIKE VIRUS (B/SINGAPORE/WUH4618/2021)

• 關聯藥證數量: 1

B/Austria/1359417/2021 (B/Victoria lineage)-like virus

• 關聯藥證數量: 1

B/Austria/1359417/2021 (B/Victoria lineage)-like virus (B/Austria/1359417/2021, BVR-26)

• 關聯藥證數量: 1

B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26)

• 關聯藥證數量: 1

B/BEIJING/184/93-LIKE STRAIN

• 關聯藥證數量: 1

B/Brisbane/60/2008-like strain (B/Brisbane/60/2008, wild type)

• 關聯藥證數量: 1

B/Colorado/06/2017-like virus (B/Maryland/15/2016, Reassortant NYMC BX-69A)

• 關聯藥證數量: 1

B/Massachusetts/02/2012

• 關聯藥證數量: 1

B/Phuket/3073/2013 (B/Yamagata lineage)

• 關聯藥證數量: 1

B/STRAIN

• 關聯藥證數量: 1

B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)

• 關聯藥證數量: 1

B/Washington/02/2019 (B/Victoria lineage)

• 關聯藥證數量: 1

B2M ANTIBODY (PROCESSED GOAT SERA) 5.0 ML B2M COREAGENT (A MIXTURE OF BOVINE AND HUMAN PROTEINS) 5.0 ML

• 關聯藥證數量: 1

B4-RD1: The concentration of nonantibody reagent is 0.2% BSA, 0.01 M potassium, 0.15 M NaCl, 0.1% NaN3.\nAntibody:\nClone:89B\nHybridoma:NS/1-Ag4-1xBALB/c\nImmunogen :Tumor cells from a patient with B cell CLL\nIg chain:IgG1\nSpecies: Mouse\nSource: Mouse Ascites or Conditioned media\nPurification: Ion Exchange or Affinity Chromatography\nFluorescence: Excites at 485-570nm/Emits at 577nm\nConjugation: RD1(Phycoerythrin)\nMolar Ratio: RD1/Protein:0.5-1.5

• 關聯藥證數量: 1

B:SERUM DILUENT (LIQUID)

• 關聯藥證數量: 1

BACAMPICILLIN (HCL)

• 關聯藥證數量: 1

BACILLUS MESENTERICUS

• 關聯藥證數量: 1

BACTERIAL LIPOLYTIC ENZYME

• 關聯藥證數量: 1

BALSALAZIDE DISODIUM DIHYDRATE

• 關聯藥證數量: 1

BALSALAZIDE DISODIUM DIHYDRATE contains 98.0~102.0% (as dried basis)

• 關聯藥證數量: 1

BAMETHAN

• 關聯藥證數量: 1

BAMIFYLLINE HCL

• 關聯藥證數量: 1

BASIC KIT COMPONENTS:\nIgE MICROPLATE coated with anti-IgE. Each well is coated with monoclonal anti-human IgE.\nHRP-STREPTAVIDIN CONJUGATE：Each vial contains 13 ml of Streptavidin-Peroxidase conjugate in a red colored buffer, pH 5.5 supplemented with 0.001% Proclin 300.\nINCUBATION BUFFER/CALIBRATOR A：Each vial contains 8 ml of TRIS buffer pH8.4, supplemented with 0.005% Proclin300. The incubation buffer of the Basic kit is used as Calibrator A (Conc. 0 KIU/L).\nSUBSTRATE HS：Each vial contains 13ml of a ready-to-use stabilized mixture of 3,3,5,5 tetramethylbenzidine and hydrogen peroxide\nSTOP SOLUTION：Each vial contains 13ml of 0.3M sulphuric acid.\nWASH BUFFER 10x：Each vial contains 100ml of a washing solution, concentrated 10x, with Amphoteric. B 2.5 μg/ml.

• 關聯藥證數量: 1

BASILIXIMAB

• 關聯藥證數量: 1

BAZEDOXIFENE ACETATE MICRONIZED

• 關聯藥證數量: 1

BCG concentrate:\nSuccinate buffer 75 mmol/l;\nBromocresol green 0.15 mmol/l;\nBrij 35;\nPreservative;\nStandard:\nHuman serum albumin 45 g/l (4.5 g/dl);\nTris Buffer 100 mmol/l

• 關聯藥證數量: 1

BCP dye, Acetate Buffer, Surfactant, Microbial inhibitor.

• 關聯藥證數量: 1

BCP, EHR, FB, FVB, JAMES, NIN, NIT1, NIT2, PY2, TDA, VP 1, VP 2, VPA, VP B, XYL, Zn, ZYMA, ZYMB。

• 關聯藥證數量: 1

BD GeneOhm StaphSR Assay\nSample buffer 48/200 tests: Tris-EDTA buffer 60 x 1/240 x 1 mL.\nLysis tube 48/200 tests: Glass beads 50/200 tubes.\nMaster mix (8 reactions each) 48/200 tests (8/34 tubes): < 0.0005% DNA polymerase complex, <0.001% Internal control-non-infectious DNA containing MRSA-primer binding sequences and a unique sequence for probe hybridization, <0.002% primers, <0.002% molecular beacon probes, <0.05% dATP, dCTP, dGTP, dTTP, Bovine serum albumin, Carbohydrate, MgCl2, <0.001% non-infectious Staphylococcus epidermidis genomic DNA (ATCC 14990).\nControl DNA 48/200 tests (8/34 tubes): Tris-EDTA buffer, Carbohydrate, <0.001% non-infectious genomic MRSA DNA (ATCC43300).\nDiluent 48/200 tests (8 x 700/34 x 700 μL): Tris-HCl buffer, MgCl2, (NH4)2SO4, KCl.

• 關聯藥證數量: 1

BD Procount CD34 reagent A (nucleic acid dye/CD34 PE/CD45 PerCP)BD Procount Control reagent B (nucleic acid dye/γ1 PE/CD45 PerCP)BD Trucount tubes (25 tubes/pouch)

• 關聯藥證數量: 1

BD 菲科思凱立博FACSCalibur？流式細胞儀一台兼具分析與分選功能的多色桌上型流式細胞分析系統，結合樣品自動上樣盤、和各式各樣的試劑，以及功能強大的分析軟體以供選擇。

• 關聯藥證數量: 1

BDIS CD19 (Leu-12) PE reagent is a monoclonal antibody provided in buffered saline with gelatin and 0.1% sodium azide and is available in 50 tests. It contains PE-labeled CD19 (Leu-12), clone 4G7.8 The CD19 antigen, 95 kDa, is expressed on virtually all human B lymphocytes, which recognize 2% to 19% of peripheral blood lymphocytes.9

• 關聯藥證數量: 1

BEADS SOLID PHASE\nANTI-hBNP 125I\nSTANDARDS 0\nSTANDARDS A to F\nCONTROLS L and H\nDILUENT\nWASHING SOLUTION

• 關聯藥證數量: 1

BECAPLERMIN

• 關聯藥證數量: 1

BECLAMIDE

• 關聯藥證數量: 1

BECLOMETHASONE

• 關聯藥證數量: 1

BEEF TALLOW

• 關聯藥證數量: 1

BELLADONNA LEAF EXTRACT

• 關聯藥證數量: 1

BEMEGRIDE

• 關聯藥證數量: 1

BENDAZAC

• 關聯藥證數量: 1

BENFLUOREX HCL

• 關聯藥證數量: 1

BENPROPERINE

• 關聯藥證數量: 1